ISN Webinar: Current evidence and the future role of non-steroidal mineralocorticoid receptor antagonists in kidney and cardiovascular disease

This webinar will provide an update on the role of non-steroidal mineralocorticoid receptor antagonists (nsMRAs) in today’s clinical kidney and cardiovascular disease landscape. The webinar will highlight both recent and ongoing clinical trial and real-world findings. Case studies will demonstrate how the recently developed MRA tool can be used in practice to support decisions. The session will also explore how nsMRAs fit into emerging combination therapy strategies.

Learning objectives:

Review key findings from recent and ongoing finerenone clinical trials.
Explore the role of nsMRAs within the landscape of combination therapies.
Consider practical applications of nsMRAs and using the recently developed MRA tool.

Further reading:

Explore more cardio-kidney resources in the ISN-led cardio-kidney-metabolic initiative toolkits.

This webinar is supported by Bayer

Roberto Pecoits-Filho

USA

Dr. Pecoits-Filho is a Senior Research Scientist at Arbor Research Collaborative for Health in Michigan, USA and a Professor of Medicine, Pontifical Catholic University of Paraná in Curitiba, Brazil. He is the current (2021-23) Chair of the Education Committee of the International Society of Nephrology. As a clinician, he has broad activities in Internal Medicine and Nephrology based at the University affiliated hospitals, where he was the Chief of the Department of Internal Medicine between 2010 and 2016, the Director of the Residency program in Nephrology from 2013 to 2016. Dr. Pecoits-Filho is the Principal Investigator for the study CKDOPPS, a multinational study on practice patterns and outcomes in chronic kidney disease and act as a Scientific Leader for clinical trials in the Americas with George Clinical. Dr. Pecoits-Filho received his MD and trained in Internal Medicine and Nephrology in Curitiba, Brazil before completing a nephrology research fellowship at the University of Missouri, Columbia and a PhD from the University of Sao Paulo. He was a visiting scholar for extended periods at the Karolinska Institute (Sweden) and the George Institute (Australia), and has participated as a principal investigator, regional leader and in steering committees in multinational clinical trials. Dr. Pecoits-Filho served as a member of the Executive Committee of the International Society of Nephrology (ISN) (2017-2019), the SONG Initiative (2017-present) and KDIGO (2016-2018).